These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17658639)

  • 1. Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats.
    Jindal S; Singh M; Balakumar P
    Int J Cardiol; 2008 Aug; 128(3):383-91. PubMed ID: 17658639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The defensive effect of benfotiamine in sodium arsenite-induced experimental vascular endothelial dysfunction.
    Verma S; Reddy K; Balakumar P
    Biol Trace Elem Res; 2010 Oct; 137(1):96-109. PubMed ID: 19943121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rosiglitazone in sodium arsenite-induced experimental vascular endothelial dysfunction.
    Kaur T; Goel RK; Balakumar P
    Arch Pharm Res; 2010 Apr; 33(4):611-8. PubMed ID: 20422371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the rat.
    Kaur J; Reddy K; Balakumar P
    Cardiovasc Toxicol; 2010 Sep; 10(3):227-38. PubMed ID: 20694523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction.
    Shah DI; Singh M
    Vascul Pharmacol; 2006 Mar; 44(3):177-82. PubMed ID: 16442349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat.
    Balakumar P; Sharma R; Singh M
    Pharmacol Res; 2008; 58(5-6):356-63. PubMed ID: 18951979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bis(maltolato) oxovanadium on experimental vascular endothelial dysfunction.
    Shah DI; Singh M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jun; 373(3):221-9. PubMed ID: 16736159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic interventions using a combination of Telmisartan and omega 3-fatty acids in sodium arsenite-induced vascular endothelial dysfunction in rats: modulation through ATP-sensitive K+ channels and eNOS.
    Nirwane A; Pawar V; Majumdar A
    J Complement Integr Med; 2015 Jun; 12(2):143-51. PubMed ID: 25870973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible vasculoprotective role of linagliptin against sodium arsenite-induced vascular endothelial dysfunction.
    Jyoti U; Kansal SK; Kumar P; Goyal S
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):167-75. PubMed ID: 26497187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glucagon-like peptide- 1 in vascular endothelial dysfunction.
    Goyal S; Kumar S; Bijjem KV; Singh M
    Indian J Exp Biol; 2010 Jan; 48(1):61-9. PubMed ID: 20358868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate attenuates nicotine-induced vascular endothelial dysfunction in the rat.
    Chakkarwar VA
    Vascul Pharmacol; 2011; 55(5-6):163-8. PubMed ID: 21864717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of attenuation of diabetes mellitus and hypercholesterolemia induced vascular endothelial dysfunction by protein tyrosine phosphatase inhibition.
    Sharma S; Singh M; Sharma PL
    Vascul Pharmacol; 2011; 54(3-6):80-7. PubMed ID: 21237289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fish oil blunted nicotine-induced vascular endothelial abnormalities possibly via activation of PPARγ-eNOS-NO signals.
    Taneja G; Mahadevan N; Balakumar P
    Cardiovasc Toxicol; 2013 Jun; 13(2):110-22. PubMed ID: 23208382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities.
    Kathuria S; Mahadevan N; Balakumar P
    Mol Cell Biochem; 2013 Feb; 374(1-2):61-72. PubMed ID: 23149826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of protein kinase A improves vascular endothelial dysfunction.
    Shah DI; Singh M
    Endothelium; 2006; 13(4):267-77. PubMed ID: 16990183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tyrosine phosphatase inhibitor bis(maltolato)oxovanadium attenuates myocardial reperfusion injury by opening ATP-sensitive potassium channels.
    Liem DA; Gho CC; Gho BC; Kazim S; Manintveld OC; Verdouw PD; Duncker DJ
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1256-62. PubMed ID: 14993257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Rho-kinase in experimental vascular endothelial dysfunction.
    Shah DI; Singh M
    Mol Cell Biochem; 2006 Feb; 283(1-2):191-9. PubMed ID: 16444602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
    J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of demethylasterriquinone b1 in hypertension associated vascular endothelial dysfunction.
    Shah DI; Singh M
    Int J Cardiol; 2007 Sep; 120(3):317-24. PubMed ID: 17240464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes.
    Dabroś W; Dziga D; Kordowiak AM
    Pol J Pathol; 2002; 53(4):205-13. PubMed ID: 12597338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.